Testing effectiveness (Phase 2)Study completedNCT05882734
What this trial is testing
Tuvusertib (M1774) in Combination With Cemiplimab in Participants With Non-Squamous NSCLC (DDRiver NSCLC 322)
Who this might be right for
Non-Small Cell Lung Cancer
EMD Serono Research & Development Institute, Inc. 61